Is Parnax Lab overvalued or undervalued?

As of 7 November 2025, Parnax Lab's valuation grade has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 13.60, an EV to EBITDA of 8.35, and a ROE of 13.86%.
In comparison to its peers, Parnax Lab's PE ratio is significantly lower than that of Elitecon International, which is considered very expensive at 378.62, and MMTC, which is also risky at 139.02. This suggests that while Parnax Lab is fairly valued, it remains more attractive relative to its overvalued peers. Despite a recent decline in stock performance, with a year-to-date return of -23.81% compared to the Sensex's 6.50%, the long-term performance remains strong, with a 5-year return of 575.46% versus the Sensex's 98.64%.